Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Opsens Inc.
  6. News
  7. Summary
    OPS   CA6838231083

OPSENS INC.

(OPS)
  Report
Delayed Quote. Delayed Toronto Stock Exchange - 12/03 05:00:00 pm
3.33 CAD   -1.48%
11/24OPSENS : Certification CEO
PU
11/24OPSENS : Certification CFO
PU
11/24Opsens Upgraded to Strong Buy at Raymond James
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

OPSENS : Says "Successfully Treats" First Patients in Human Clinical Study for TAVR Procedure

10/13/2021 | 08:36am EST


ę MT Newswires 2021
All news about OPSENS INC.
11/24OPSENS : Certification CEO
PU
11/24OPSENS : Certification CFO
PU
11/24Opsens Upgraded to Strong Buy at Raymond James
MT
11/23OpSens Reports Q4 $1.2 Million Net Loss; Successfully Completes 20-Patient in Human Cli..
MT
11/23OPSENS BRIEF : Adds Net Loss was $1.2 Million during Q4 2021 Vs Net Income of $0.6 Million..
MT
11/23OPSENS BRIEF : Says Total Revenue was $8.1 Million in Q4 2021 Compared With $7.6 million i..
MT
11/23OpSens Announces Fourth Quarter And Fiscal Year 2021 Financial Results
AQ
11/23Opsens Inc. Reports Earnings Results for the Fourth Quarter Ended August 31, 2021
CI
11/23OPSENS BRIEF : Says Successfully Completed 20-Patient in Human Clinical Study for TAVR Pro..
MT
11/23OpSens Successfully Completes 20-Patient in Human Clinical Study for TAVR Procedure
AQ
More news
Analyst Recommendations on OPSENS INC.
More recommendations
Financials
Sales 2021 34,5 M 26,8 M 26,8 M
Net income 2021 -1,15 M -0,90 M -0,90 M
Net cash 2021 26,4 M 20,6 M 20,6 M
P/E ratio 2021 -227x
Yield 2021 -
Capitalization 360 M 281 M 280 M
EV / Sales 2020 2,46x
EV / Sales 2021 7,43x
Nbr of Employees 163
Free-Float 95,1%
Chart OPSENS INC.
Duration : Period :
Opsens Inc. Technical Analysis Chart | OPS | CA6838231083 | MarketScreener
Technical analysis trends OPSENS INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 3,33 CAD
Average target price 4,28 CAD
Spread / Average Target 28,5%
EPS Revisions
Managers and Directors
Louis Laflamme President, Chief Executive Officer & Director
Robin Villeneuve Chief Financial Officer & Secretary
Alan W. Milinazzo Executive Chairman
Jean Lavigueur Independent Director
Denis L. Harrington Independent Director
Sector and Competitors
1st jan.Capi. (M$)
OPSENS INC.156.39%281
THERMO FISHER SCIENTIFIC36.57%250 658
DANAHER CORPORATION40.88%223 620
INTUITIVE SURGICAL, INC.20.03%114 898
SIEMENS HEALTHINEERS AG52.50%80 761
EDWARDS LIFESCIENCES CORPORATION20.38%67 728